Dr. Catherine Tisdall, MD

Areas of expertise and specialization

Faculty Titles & Positions

• Local Public Speaking -
• Former Assistant Professor of Dermatology, Penn State -

Awards

• America's Top Dermatologist 2009, 2010, 2011, 2013   
• Patients' Choice Award 2010, 2011, 2012   
• Texas Rising Stars 2012, 2013   
• Peer Reviewed Physicians 2013   
• Most Compassionate Doctor 2011   
• S.A. Doctors, Best of 2013, 2014   
• 2005 Medical Dermatology Society Mentorship, Dr. Werth, U of Pennsylvania   
• 2002 Graduation with Honors, University of Washington Medical School   

Treatments

• Acne
• Eczema
• Dermatitis
• Rosacea
• Moles
• Seborrheic Dermatitis
• Actinic Keratosis
• Birthmark
• Contact Dermatitis
• Fungal Infection
• Nail Fungus
• Rash
• Seborrheic Keratosis
• Natural Hormone Balancing

Areas of research

2012 -              Sub- Investigator,  A Phase 3 Study to Evaluate the Efficacy and

Safety  of Induction and Maintenance Regimens of an Investigational

                        Injectable Medication Compared With Placebo and An Approved

                        Injectable Medication in Subjects With Moderate to Severe Plaque

                        Psoriasis.

2012 -             Sub-Investigator,  A 12-Week Multicenter, Randomized, Double-

Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of an Investigational Injectable Medication to an Approved Injectable Medication and Placebo in Patients With Moderate to Severe Plaque Psoriasis With a Long-Term Extension Period.         

2012 – 2013   Sub-Investigator, A Randomized, double-Blind, Multiple-Site,

                        Placebo-Controlled, Parallel Design Study comparing two topical gels in

                        the treatment of Actinic Keratosis.

2012 -              Sub-Investigator, A Randomized, Multi-Center, Investigator-Blind, Vehicle-and Active-Controlled, Phase 2 Study To Assess The Efficacy And Safety Of Different Concentrations of A Topical Cream Applied Once Daily in subjects With Moderate To Severe Acne Vulgaris.

2012 – 2013    Sub-Investigator, A Phase 3 Randomized, a 12-week Vehicle-Controlled, Parallel-group Study Assessing the Efficacy and Safety of a Topical medication in Subjects with Papulopustular Rosacea, followed by a 40 Week Investigator-Blinded Extension Comparing the Long-term Safety of a Topical Cream Versus a Gel.

2011 -2012     Sub-Investigator, A Randomized, Double-blind, Placebo-Controlled,

Multiple-site, Study Comparing 2 Topical Gels in the Treatment of Moderate to Severe Rosacea.

2011- 2012      Sub-Investigator, An Open-Label  Study to Evaluate the Safety of Long-Term Administration of a Topical Cream in Subjects With Tinea Pedis, Tinea Corporis, or Tinea Cruris.

2011 - 2012     Sub-Investigator, A Randomized, Multi-Center, Double-Blind, Vehicle-controlled Study Evaluating the Efficacy And Safety of a Topical Cream in Subjects With Tinea Pedis.

2011 -              Sub-Investigator, A Randomized, Double-Blind, Double-dummy, Placebo Controlled, Multicenter Study of an Injectable  Medication to Demonstrate Efficacy After 12 Weeks of Treatment, Compared to Placebo and an Injectable Medication, and to Assess the Safety , Tolerability and Long-term Efficacy up to One year In Subjects With Moderate to Severe Chronic Plaque –Type Psoriasis.                                                                    4

2011 – 2012    Sub-Investigator, A Randomized, Multi-Center, Double-Blind, Vehicle-Controlled  Study evaluating the Efficacy and Safety of a Topical medication in Subjects with Tinea Cruris.

2011 –  2012   Sub-Investigator, a Multi-Center, Randomized, Double-Blind, Placebo-

Controlled, 3-Arm, Parallel Group Study comparing the Efficacy and Safety of an oral medication versus placebo and an antibiotic once daily in the Treatment of Inflammatory Lesions in Subjects with Acne Vulgaris.

2011 -              Sub-Investigator, A Phase 3, Multi-Site, Open-Label Study of the Long Term Safety and Tolerability of 2 Doses of an Oral Medication in Subjects With Moderate To Severe Chronic Plaque Psoriasis.

2010 - 2013     Sub-Investigator, A Phase 3, Multi-Site, Randomized, Mixed-Blind, Parallel-Group Treatment Withdrawal and Re-treatment Study of the Efficacy and Safety of  an oral medication  in Subjects With Moderate to Severe Chronic Plaque Psoriasis.

2009- 2011      Sub-Investigator, A Phase 3, Multicenter, Randomized, Double-Blind Study Evaluating the Safety  and Efficacy of a topical solution versus Vehicle in Subjects with Mild to Moderate Onychomycosis of the Toenails.

2009- 2011      Sub-Investigator,  A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of adding an oral medication to an injectable medication in Subjects With Moderate to Severe Plaque Psoriasis.

2009- 2011      Sub-Investigator, A double-blind, randomized, Phase 3, parallel group study evaluating the efficacy and safety of an oral medication in patients with severe recalcitrant nodular acne.

2009-2009       Sub-Investigator, A Phase 3, double-blind, randomized, parallel-group, vehicle- controlled, multicenter study to compare the safety and efficacy of a topical medication in the treatment of Actinic Keratosis.

2008-2009       Sub- Investigator,  A Phase 3, multicenter, randomized, controlled,

parallel-group study comparing the efficacy of a topical medication associated with an oral medication in the treatment of severe acne vulgaris.

Dr. Catherine Tisdall, MD's Practice location